Sunshine Biopharma Inc. Accounts Payable
Sunshine Biopharma Inc. (SBFM) had Accounts Payable of $4.85 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $4.85M.
- 2026-03-31: Accounts Payable, Current $5.10M.
- 2025-12-31: Accounts Payable, Current $5.66M.
- 2025-09-30: Accounts Payable, Current $6.14M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.85M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.10M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.66M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $6.14M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.80M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.02M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $5.54M 10-K · filed 2026-04-03 | |
| 2024-09-30 | $4.16M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $4.93M 10-Q/A · filed 2024-08-20 | |
| 2024-03-31 | $3.62M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $2.59M 10-K · filed 2025-04-01 | |
| 2023-09-30 | $2.22M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.76M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.74M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.80M 10-K · filed 2024-03-28 | $2.80M 10-K · filed 2023-04-04 |
| 2022-09-30 | $480.21K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $104.68K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $95.23K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $42.94K 10-K · filed 2023-04-04 | |
| 2021-09-30 | $56.69K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $103.19K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $148.56K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $62.87K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $57.69K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $89.88K 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $97.96K 10-Q · filed 2020-05-18 | |
| 2019-12-31 | $96.88K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $64.83K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $84.38K 10-Q · filed 2019-08-15 | |
| 2019-03-31 | $140.34K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $115.83K 10-K · filed 2020-05-01 | $191.08K 10-K · filed 2019-04-12 |
| 2018-09-30 | $104.99K 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $139.02K 10-Q · filed 2018-08-17 | |
| 2018-03-31 | $113.36K 10-Q · filed 2018-05-22 | |
| 2017-12-31 | $19.31K 10-K · filed 2019-04-12 | |
| 2017-09-30 | $12.11K 10-Q · filed 2017-11-15 | |
| 2017-06-30 | $34.71K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $27.95K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $28.12K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $19.28K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $35.71K 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $24.48K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $46.59K 10-K · filed 2017-04-17 | |
| 2015-09-30 | $34.64K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $35.67K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $46.60K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $34.77K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $51.32K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $93.87K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $49.51K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $23.81K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $8.76K 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $293.00 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $8.34K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $595.00 10-K · filed 2014-03-19 | |
| 2012-09-30 | $1.59K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $16.50K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $8.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $3.43K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $4.54K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $330.00 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $11.40K 10-K · filed 2012-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |